683 Capital Management, LLC Uni Qure N.V. Transaction History

683 Capital Management, LLC

$1.17 Billion
Q1 2024

A detailed history of 683 Capital Management, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, 683 Capital Management, LLC holds 1,975,000 shares of QURE stock, worth $8.81 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

1,975,000

Previous 1,693,000 16.66%

Holding current value

$8.81 Million

Previous $11.5 Million 10.39%

% of portfolio

0.88%

Previous 1.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $1.36 Million - $1.95 Million	282,000 Added 16.66%	1,975,000 $10.3 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $664,340 - $975,860	118,000 Added 7.49%	1,693,000 $11.5 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $1.88 Million - $3.31 Million	280,000 Added 21.62%	1,575,000 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $2.25 Million - $4.48 Million	202,000 Added 18.48%	1,295,000 $14.8 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $972,400 - $1.2 Million	-52,000 Reduced 4.54%	1,093,000 $22 Million

Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $4.14 Million - $6.25 Million	-228,600 Reduced 16.64%	1,145,000 $26 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $315,828 - $475,044	18,600 Added 1.37%	1,373,600 $25.8 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $1.48 Million - $2.19 Million	101,800 Added 8.12%	1,355,000 $24.5 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $11 Million - $19.5 Million	541,845 Added 76.17%	1,253,200 $26 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $11.2 Million - $16.4 Million	428,839 Added 151.79%	711,355 $22.8 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $5.77 Million - $8.3 Million	-197,484 Reduced 41.14%	282,516 $9.52 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $450,600 - $677,400	-10,000 Reduced 2.04%	480,000 $21.6 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $2.97 Million - $5.97 Million	-80,000 Reduced 14.04%	490,000 $35.1 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $2.76 Million - $5.38 Million	70,000 Added 14.0%	570,000 $22.4 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $13.2 Million - $20.5 Million	-250,000 Reduced 33.33%	500,000 $39.1 Million
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $9.18 Million - $22.9 Million	-335,000 Reduced 30.88%	750,000 $44.7 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $2.3 Million - $3.42 Million	100,900 Added 10.25%	1,085,000 $31.3 Million
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $1.96 Million - $2.84 Million	-65,900 Reduced 6.28%	984,100 $35.8 Million
Q3 2017 Nov 14, 2017	BUY	$7.7 - $9.6 $5.97 Million - $7.44 Million	774,999 Added 281.82%	1,050,000 $10.1 Million
Q4 2016 Dec 07, 2017	BUY	N/A	275,001	275,001 $1.54 Million

Others Institutions Holding QURE

# of Institutions

149

Shares Held

34.1M

Call Options Held

1.07M

Put Options Held

603K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $208M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account

683 Capital Management, LLC Uni Qure N.V. Transaction History